EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Inhaled short-acting beta-2 agonist- induced supra-ventricular tachycardia in children: A case report and comprehensive literature review

Mohammad Alesali, Senussi Elbeshti, Sana Sallem, Mohammad Zakaria Alaboud

Journal of Emergency Medicine, Trauma & Acute Care · 2026 · 2026 (2)

DOI: 10.5339/jemtac.2026.35 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Emergency Medicine, Trauma & Acute Care, 2026. Verfasst von Mohammad Alesali und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Supra-ventricular tachycardia (SVT) is a common, potentially serious arrhythmia in the pediatric population. Congenital cardiac anomalies and electrical pathway abnormalities are established predisposing factors. The incidence of SVT following short-acting beta-2 agonist inhalation is a sparsely documented adverse event. Case Presentation : A 13-month-old female was brought to the pediatric emergency department with respiratory distress and developed SVT following a single dose of salbutamol nebulization. The vagal maneuver failed to resolve SVT, while intravenous adenosine converted the SVT. Subsequent electrocardiogram showed Wolff-Parkinson-White (WPW) syndrome features, and the echocardiogram revealed an Epstein anomaly. The patient was discharged in stable condition on oral propranolol, with follow-up appointments and a future ablation plan.

Discussion

Inhaled short-acting beta-2 agonists can affect cardiac tissue and may induce SVT, especially in patients with pre-existing cardiac conditions. To explore this association, we conducted a systematic literature search. While existing literature suggests a potential link between beta-2 agonist use and SVT, the evidence base is limited, mainly consisting of small retrospective studies and case reports that are inherently susceptible to bias and confounding factors.

Conclusion

Given the potential for short-acting beta agonists to induce arrhythmias, like SVT, close observation and monitoring are crucial for children receiving beta-agonist nebulization, especially those with pre-existing cardiac conditions. Additional research is recommended.

Zitieren

APA

Alesali, M., Elbeshti, S., Sallem, S., & Alaboud, M. Z. (2026). Inhaled short-acting beta-2 agonist- induced supra-ventricular tachycardia in children: A case report and comprehensive literature review. Journal of Emergency Medicine, Trauma & Acute Care, 2026(2). https://doi.org/10.5339/jemtac.2026.35

Vancouver

Alesali M, Elbeshti S, Sallem S, Alaboud MZ. Inhaled short-acting beta-2 agonist- induced supra-ventricular tachycardia in children: A case report and comprehensive literature review. Journal of Emergency Medicine, Trauma & Acute Care. 2026;2026(2). doi:10.5339/jemtac.2026.35

BibTeX
@article{Alesali2026,
  author = {Alesali, Mohammad and Elbeshti, Senussi and Sallem, Sana and Alaboud, Mohammad Zakaria},
  title = {Inhaled short-acting beta-2 agonist- induced supra-ventricular tachycardia in children: A case report and comprehensive literature review},
  journal = {Journal of Emergency Medicine, Trauma & Acute Care},
  year = {2026},
  volume = {2026},
  number = {2},
  doi = {10.5339/jemtac.2026.35}
}
Kostenlos starten →